Request Information


Media coverage of Auris Health

Contact us

Auris Featured on MedCity News for Johnson & Johnson Acquisition

Auris was featured on MedCity News, an online publication covering the business of healthcare innovation, for its recent acquisition by Johnson & Johnson. Seeking to expand their digital surgery business, J&J paid $3.4 billion in cash to acquire Auris. Auris is also eligible to receive up to $2.3 billion in additional payments from J&J after hitting predetermined milestones. Auris will be included as part of Ethicon, J&J's medical device subsidiary.

Continue Reading

Auris Featured in Medium Article by Lux Co-Founder & Managing Partner

Peter Hébert, co-founder and Managing Partner of Lux, wrote an article about Auris that was published in Medium. Believing strongly in Auris's mission, Lux co-led Auris Health's Series A financing in 2012 and has invested nearly $50 million since the company's inception. On the heels of Auris's recent acquisition by Johnson & Johnson, Hébert's article highlights Auris's mission and how J&J will help to further that mission.

Continue Reading

TechCrunch Features Auris in Article About J&J Purchase

Auris was featured in an article on TechCrunch, an online publication that covers the tech industry, about the recent announcement that Johnson & Johnson will acquire Auris for $3.4 billion in cash.

Continue Reading

J&J Acquisition of Auris Featured on FierceBiotech

FierceBiotech featured Auris in an article about Johnson & Johnson's $3.4 billion all-cash agreement to acquire Auris Health. Auris could receive up to $2.35 billion in additional payments by hitting certain milestones. FierceBiotech previously named Auris among their "Fierce 15" in medtech in 2017.

Continue Reading

Monarch™ Platform Takes Center Stage at SXSW in Austin

Many come for the entertainment, others come for innovation. The Monarch™ Platform has been announced as a finalist for SXSW’s Interactive Innovation Award. Auris Health, creators of the first-of-its-kind technology, and Fjord, Accenture Interactive’s global design and innovation consultancy involved in the development of the system, are being honored for their joint innovation and efforts to revolutionize endoscopy.

Continue Reading

Auris Featured in Forbes Among Healthcare Startups Raising Venture Capital

According to Forbes, healthcare startups raised $28.8 billion in venture capital funding from January 2018 through November 2018. This is up 50% from last year over the same time frame, according to an analysis conducted for Forbes by Pitchbook.

Continue Reading

Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot

Auris Health is featured in Xconomy for its recent round of fundraising. Auris Health was able to raise an additional $220 million in funding to further bolster its commercialization efforts. Auris received clearance from the FDA to sell the first robotic bronchoscope offered on the Monarch Platform.

Continue Reading

Auris Supports Lung Cancer Awareness Month

November is Lung Cancer Awareness Month (LCAM). Auris is proud to raise awareness and support the education of lung cancer, a disease that kills more people than breast, colon and prostate cancer combined. Throughout the month on our social media, we share articles and interviews on lung cancer research and promote lung cancer survivor stories. View our infographic to learn quick facts of this deadly disease and the evolution of biopsy methods overs the years.

Continue Reading

Kyle Bramley discusses Robotic assisted bronchoscopy biopsy presentation at CHEST

Dr Kyle Bramley is interviewed at CHEST about the study presented at CHEST by Alex Chen, M.D. on robotic assisted bronchscopic biopsy of peripheral pulmonary lesions in a cadaveric model with simulated tumor targets.

Continue Reading

Auris Health Announces Results from Study of MONARCH® Platform at CHEST 2018 Late-Breaking Abstracts

Auris Health, Inc. announced the results of the Nodule Access study at the CHEST 2018 Annual Meeting in San Antonio. Alexander C. Chen, M.D., Director of Interventional Pulmonology at Washington University of St. Louis, shared the findings during the Late-Breaking Abstract session.

Continue Reading